info@synchemia.com | sales@synchemia.com 
9766925136 
Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142403 |
| CAS No | NA |
| Mol.F. | C16H15N3O2 |
| Mol.Wt. | 281.32 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142404 |
| CAS No | NA |
| Mol.F. | C4H8N2O3 |
| Mol.Wt. | 132.12 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142405 |
| CAS No | NA |
| Mol.F. | C17H15ClN2O4 |
| Mol.Wt. | 346.77 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142406 |
| CAS No | NA |
| Mol.F. | C16H13ClN2O2 |
| Mol.Wt. | 300.74 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142407 |
| CAS No | NA |
| Mol.F. | C8H13N3OS |
| Mol.Wt. | 199.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142408 |
| CAS No | NA |
| Mol.F. | C28H30FN5O2 |
| Mol.Wt. | 487.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142409 |
| CAS No | NA |
| Mol.F. | C29H33FN5O2 |
| Mol.Wt. | 521.61 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142410 |
| CAS No | NA |
| Mol.F. | C8H13N3OS |
| Mol.Wt. | 199.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142411 |
| CAS No | NA |
| Mol.F. | C38H51N7O8 |
| Mol.Wt. | 733.87 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142412 |
| CAS No | NA |
| Mol.F. | C17H20N4O3 |
| Mol.Wt. | 328.37 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142413 |
| CAS No | NA |
| Mol.F. | C12H18N4O |
| Mol.Wt. | 234.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142414 |
| CAS No | NA |
| Mol.F. | C12H18N4O |
| Mol.Wt. | 234.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142415 |
| CAS No | NA |
| Mol.F. | C18H22N6O4 |
| Mol.Wt. | 386.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142416 |
| CAS No | NA |
| Mol.F. | C22H28N4O7 |
| Mol.Wt. | 460,.49 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142417 |
| CAS No | NA |
| Mol.F. | C14H21N3O5 |
| Mol.Wt. | 311.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142418 |
| CAS No | NA |
| Mol.F. | C20H29N3O10 |
| Mol.Wt. | 471.16 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
